MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    GP2: training the next generation of Parkinson’s disease genetics researchers – wherever they are in the world

    S. Dey, A. Noyce, C. Bale, M. Kuhl, H. Leonard, P. Lewis, S. Stott, S. Adams, A. Martinez-Carrasco, B. Stecher, S. Bandres-Ciga, G. Genetics Program (London, United Kingdom)

    Objective: To establish a virtual ‘center of excellence’ with resources and expertise to serve the training needs of the Global Parkinson’s Genetics Program (GP2; www.gp2.org)…
  • MDS Virtual Congress 2021

    Monogenic Portal of the Global Parkinson’s Genetics Program (GP2)

    SY. Lim, LM. Lange, H. Madoev, KR. Kumar, AH. Tan, M. Avenali, P. Heutink, EJ. Vollstedt, K. Lohmann, N. Mencacci, C. Klein, EM. Valente (Kuala Lumpur, Malaysia)

    Objective: To support the efforts of the Global Parkinson’s Genetics Program (GP2, http://gp2.org/) Monogenic Hub, by developing an easy-to-use online platform for case/family submission. Background:…
  • MDS Virtual Congress 2021

    Stratified genome-wide association study revealed novel interactions for the top hit Parkinson’s disease loci.

    K. Senkevich, S. Bandres-Ciga, E. Yu, L. Krohn, Z. Gan-Or (Montreal, Canada)

    Objective: To identify genetic modifiers and interactors that may modulate known risk variants in the SNCA, TMEM175 and MAPT loci in Parkinson’s disease (PD). Background:…
  • MDS Virtual Congress 2021

    Antioxidants in foods: A Primary Potential remedy to Neurodegeneration.

    B. Adebisi (Osogbo, Nigeria)

    Objective: The aim of the research is to establish the plausibility of reducing the effects of the actions of reactive oxygen species, produced by glutamate…
  • MDS Virtual Congress 2021

    The gut microbiome in Parkinson’s disease: longitudinal insights into disease progression and the use of device-assisted therapies.

    M. Lubomski, X. Xu, A. Holmes, S. Mueller, J. Yang, C. Sue, R. Davis (St Leonards, Australia)

    Objective: We investigated the temporal stability of gut microbiome (GM) profiles from Parkinson’s disease (PD) patients initiating device-assisted therapies (DAT) and in a separate cohort…
  • MDS Virtual Congress 2021

    RNA Editing in Parkinson’s Disease Shows Changes in Mitochondrial and Manganese-Binding Pathways in Multiple Brain Regions

    A. Thele, O. Gardner, J. Vance, A. Griswold, J. Young, M. Pericak-Vance, W. Scott, E. Martin, W. Wang, D. Dykxhoorn, C. Petito, G. Beecham, D. Mash, S. Sivasankaran (Miami, USA)

    Objective: To identify RNA editing alterations associated with Parkinson’s disease (PD) in the Dorsal Motor Nucleus of the Vagus (DMV), Substantia Nigra (SN), and Cingulate…
  • MDS Virtual Congress 2021

    Deep learning based detection of Parkinson’s disease (PD) in Magnetic Resonance Imaging (MRI) brain scans

    M. Courtman, L. Sun, E. Ifeachor, S. Mullin (Plymouth, United Kingdom)

    Objective: To use a deep learning based framework to classify MRI brain scans as PD or control cases. Background: The Parkinson’s Progression Markers Initiative provides…
  • MDS Virtual Congress 2021

    Usefulness of substantia nigra evaluation by transcranial ultrasonography in the diagnosis of Parkinson’s disease

    S. Hino, H. Mizukami, Y. Hagiwara, M. Futaba, M. Kaburagi, H. Matsumoto, M. Shiraishi, Y. Yamano (Kawasaki, Japan)

    Objective: To investigate the usefulness of transcranial ultrasonography (TCS) in the diagnosis of Japanese patients with Parkinson’s disease (PD). Background: There are many reports on…
  • MDS Virtual Congress 2021

    The association of β-amyloid with cognition and striatal dopamine in early, non-demented Parkinson’s disease

    YS. Oh, SW. Yoo, CH. Lyoo, KS. Lee, JS. Kim (Seoul, Republic of Korea)

    Objective: The purpose of this study was to investigate the association among striatal dopaminergic availability, Aβ-positivity, and motor and cognitive status in early and non-demented…
  • MDS Virtual Congress 2021

    Cognition-related functional topographies in Parkinson’s disease: Localized loss of the ventral default mode network

    K. Schindlbeck, A. Vo, P. Mattis, K. Villringer, F. Marzinzik, J. Fiebach, D. Eidelberg (Manhasset, USA)

    Objective: We sought to determine whether functional network abnormalities seen in patients with Parkinson’s disease (PD) and cognitive decline reflect the loss of the default…
  • « Previous Page
  • 1
  • …
  • 50
  • 51
  • 52
  • 53
  • 54
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley